LRIG1 and glioblastoma: The ectodomain of LRIG1 has been used as a soluble compound in patient-derived glioblastoma models in vivo with promising results, and the drug resveratrol has been found to inhibit glioma cell growth and promote its apoptosis by upregulating LRIG1 gene expression [44, 45].